Lexicon Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation
Lexicon Pharmaceuticals Inc LXRX
$2.20
▼ -0.45%
($-0.01)
Open
$2.16
Prev Close
$2.21
Day Range
$2.11 – $2.26
52W Range
$0.52 – $2.53
Market Cap
$981.67M
Beta
1.02
EPS (TTM)
$-0.14
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2000-04-07 |
| Shares Out. | 444,200,000 |
| Website | lexpharma.com/ ↗ |
| Phone | 12818633000 |
Lexicon Pharmaceuticals Inc is a publicly traded company under the ticker symbol LXRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-05-01)
📰 Latest News for LXRX
Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
12 Health Care Stocks Moving In Monday's Intraday Session
Citigroup Maintains Buy on Lexicon Pharmaceuticals, Raises Price Target to $3.1
Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2026 Earnings Call Transcript
Transcript : Lexicon Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 07, 2026
Lexicon Pharmaceuticals (LXRX) Reports Break-Even Earnings for Q1
Lexicon Pharmaceuticals (NASDAQ:LXRX) Q1 2026 Results Show Revenue Beat and Narrowed Loss